Retrospective analysis of the safety profile and clinical, radiological and PSA evolution in metastatic castration resistant prostate cancer (MCRPC), chemotherapy naïve patients treated with abiratarone acetate (AA)

Autor: Couselo Paniagua, M., López Carrizosa, M., Samper Ots, P., Zapatero Ortuño, J., Jerviz Guía, V., Ibañez Villoslada, C., Saez Garrido, J., Dominguez Morcillo, M., Martin de Miguel, M.
Zdroj: In Reports of Practical Oncology & Radiotherapy June 2013 18 Supplement 1:S333-S333
Databáze: ScienceDirect